Cardiovascular and pulmonary effects of beta-blocking agents: implications for their use in ophthalmology.
Collignon
P
P
Department of Medicine, University of Liege, Belgium.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000367:Age Factors; D015784:Betaxolol; D002319:Cardiovascular System / Q000187:drug effects*; D004347:Drug Interactions; D005901:Glaucoma / Q000188:drug therapy*; D006331:Heart Diseases / Q000150:complications; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008168:Lung / Q000187:drug effects*; D008171:Lung Diseases / Q000150:complications; D011412:Propanolamines / Q000494:pharmacology; D013999:Timolol / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D013999:Timolol; D015784:Betaxolol